Abstract:Primary sclerosing cholangitis (PSC) is a devastating chronic cholestatic liver disease without effective therapy due to a limited understanding of its pathogenesis. The multidrug resistance gene 2‐knockout (Mdr2KO) mice spontaneously develop hepatobiliary injury, fibrosis, and hepatocellular carcinoma (HCC) closely resembling PSC. Previous studies have shown that accumulation of conjugated primary bile acid, such as taurocholic acid (TCA), contributes to the disease progression via activation of sphingosine‐1 phosphate receptor 2 (S1PR2)/sphingosine kinase 2 (SphK2). However, the underlying mechanisms remain to be fully identified. MicroRNAs (miRs) are small non‐coding RNAs that play essential roles in regulating various cellular pathways under both physiological and pathological conditions. The expression level of miR155 is correlated to the activation of inflammation and hepatic fibrosis. The aim of this study is to examine the role of SphK2 in bile acid‐induced cholestatic injury. Methods Wild type (WT) and Mdr2KO mice (age and gender‐matched) were treated with a specific Sphk2 inhibitor ABC294640 (50 mg/kg) by daily gavage for 4 weeks. Blood and liver tissues were collected. The serum levels of ALT, AST, and ALP levels were measured using the commercial kits. Liver tissues were processed for H&E and Masson’s trichrome staining, immunohistochemistry (IHC), and isolation of total RNA. The hepatic miR155 expression levels were analyzed using Taqman microRNA assays. The mRNA levels of the key genes involved in hepatic inflammation, fibrotic injury, and bile acid metabolism were measured by real‐time RT PCR. The protein levels of S1PR2 and SphK2 were determined by Western Blot analysis. The effect of TCA on miR155 expression in mouse cholangiocyte was determined. Results Compared to the gender/age‐matched WT mice, Mdr2 KO mice developed severe hepatobiliary injury as indicated by the upregulation of ALP, AST, and ALT, activation of the inflammatory response, and increase of liver fibrosis. The expression levels of S1PR2, SphK2, and miR155 were significantly increased in Mdr2KO mice. Treatment of ABC294640 significantly reduced hepatic macrophage infiltration, fibrotic liver injury, and expression of inflammatory mediators, including IL‐1β, MCP‐1, IL‐18, and IL‐6. In cultured mouse cholangiocytes, TCA significantly increased miR155 expression. Conclusion Bile acid‐induced activation of S1PR2/SphK2 may play critical roles in cholestatic liver fibrosis by the upreguation of miR155 and inflammatory mediators. Targeting SphK2 represents a potential therapeutic strategy for the treatment of the cholestatic liver injury. Support or Funding Information This work was supported by VA Merit Award I01BX004033 and 1I01BX001390, VA Career Scientist Award IK6BX004477 and National Institutes of Health Grant R01 DK104893 and R01DK‐057543

Wnt/β-Catenin signaling plays a protective role in the Mdr2 KO murine model of cholestatic liver disease.

Loss of β-catenin reveals a role for glutathione in regulating oxidative stress during cholestatic liver disease

Mice with Hepatic Loss of the Desmosomal Protein Γ-Catenin Are Prone to Cholestatic Injury and Chemical Carcinogenesis

Disturbance of Cell Signal Pathways and Genes in Nrf2 Kockout Mice after Common Bile Duct Ligation

Hepatocyte specific expression of an oncogenic variant of β-catenin results in cholestatic liver disease

Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor Deficiency Promotes the Ductular Reaction, Macrophage Accumulation, and Hepatic Fibrosis in the Abcb4-/- Mouse

Change in lipid profile and impairment of endothelium-dependent relaxation of blood vessels in rats after bile duct ligation.

β-Catenin-NFkB-CFTR interactions in cholangiocytes regulate inflammation and fibrosis during ductular reaction

The Role of Sphingosine 1‐phosphate Receptor 2 in Bile‐acid–induced Cholangiocyte Proliferation and Cholestasis‐induced Liver Injury in Mice

Tissue Repair in the Mouse Liver Following Acute Carbon Tetrachloride Depends on Injury-Induced Wnt/β-Catenin Signaling.

A Mouse Model of Cholestasis-Associated Cholangiocarcinoma and Transcription Factors Involved in Progression

Activated Hepatic Stellate Cells and Portal Fibroblasts Contribute to Cholestatic Liver Fibrosis in MDR2 Knockout Mice

Conditional Beta-Catenin Loss in Mice Promotes Chemical Hepatocarcinogenesis: Role of Oxidative Stress and Platelet-Derived Growth Factor Receptor Alpha/Phosphoinositide 3-Kinase Signaling

Effect of Bile Duct Ligation on Bile Acid Composition in Mouse Serum and Liver

Oral N-acetylcysteine ameliorates liver fibrosis and enhances regenerative responses in Mdr2 knockout mice

The Selective NLRP3 Inflammasome Inhibitor MCC950 Alleviates Cholestatic Liver Injury and Fibrosis in Mice

Peripherally Restricted CB1 Receptor Inverse Agonist JD5037 Treatment Exacerbates Liver Injury in MDR2-Deficient Mice

Mammalian Target of Rapamycin Complex 2 Signaling is Required for Liver Regeneration in a Cholestatic Liver Injury Murine Model.

Crosstalk of LKB1‐regulated and PTEN‐regulated Signals in Liver Morphogenesis and Tumor Development in Mice

Sphingosine kinase 2 plays a critical role in bile acid‐induced cholestatic liver injury <i>via</i> regulating miR‐155 and macrophage activation

Atypical cholangiocytes derived from hepatocyte-cholangiocyte transdifferentiation mediated by COX-2: a kind of misguided liver regeneration